Scarica l'app Stockscreener
12.20
11.93%
1.30
Precedente Chiudi:
$10.90
Aprire:
$11.3
Volume 24 ore:
163.81K
Relative Volume:
1.30
Capitalizzazione di mercato:
$210.56M
Reddito:
-
Utile/perdita netta:
$-33.82M
Rapporto P/E:
-0.4768
EPS:
-25.5891
Flusso di cassa netto:
$-66.04M
1 W Prestazione:
+4.90%
1M Prestazione:
+42.69%
6M Prestazione:
+6.09%
1 anno Prestazione:
+54.43%
Intervallo 1D:
$10.70
$12.77
Intervallo di 1 settimana:
$10.70
$13.57
Portata 52W:
$4.60
$14.93
Elicio Therapeutics Inc Stock (ELTX) Company Profile
Nome
Elicio Therapeutics Inc
Settore
Industria
Telefono
(857) 209-0050
Indirizzo
451 D STREET, 5TH FLOOR, BOSTON
Compare ELTX vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ELTX
Elicio Therapeutics Inc
|
12.20 | 210.56M | 0 | -33.82M | -66.04M | -25.59 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 119.23B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.84B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.35B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 41.57B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Elicio Therapeutics Inc Stock (ELTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-10 | Iniziato | Rodman & Renshaw | Buy |
Elicio Therapeutics Inc Borsa (ELTX) Ultime notizie
(ELTX) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Elicio Therapeutics: Q4 Earnings Snapshot - theheraldreview.com
Elicio Therapeutics: Fourth Quarter Financial Overview - Bitget
Elicio Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Updates - Bitget
Elicio Therapeutics (NASDAQ: ELTX) highlights KRAS cancer vaccine and AMP platform - Stock Titan
Elicio Therapeutics 10-K: Net loss $(39.6)M, EPS $(2.58) — Y/E Dec 31, 2025 - TradingView
Elicio Therapeutics (Nasdaq: ELTX) narrows 2025 loss and advances ELI-002 toward Phase 3 - Stock Titan
CEO Change: Does Elicio Therapeutics Inc meet Warren Buffetts criteria2026 Big Picture & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Rodman & Renshaw initiates Elicio Therapeutics stock with buy rating By Investing.com - Investing.com South Africa
Rodman & Renshaw initiates Elicio Therapeutics stock with buy rating - Investing.com Nigeria
Whats next for Elicio Therapeutics Inc stock2026 Price Action Summary & Short-Term High Return Ideas - baoquankhu1.vn
Aug Closing: Is Elicio Therapeutics Inc a turnaround storyDay Trade & Safe Investment Capital Preservation Plans - baoquankhu1.vn
How (ELTX) Movements Inform Risk Allocation Models - Stock Traders Daily
Elicio Therapeutics (NASDAQ: ELTX) files S-3/A delaying effective date - Stock Titan
Elicio Therapeutics Files $400 Million Mixed Shelf - marketscreener.com
Elicio Therapeutics to issue up to $400 million in securities - marketscreener.com
Elicio Therapeutics To Issue Up To $400 Million In Securities - TradingView
Elicio Therapeutics (NASDAQ: ELTX) files $400M shelf to offer stock, debt - Stock Titan
Analyst Downgrade: Can Elicio Therapeutics Inc lead its sector in growthFed Meeting & High Accuracy Swing Trade Signals - baoquankhu1.vn
Elicio Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference - Bitget
Cancer immunotherapy firm Elicio to speak at TD Cowen health conference March 4 - Stock Titan
ELTX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Can Elicio Therapeutics Inc. lead its sector in growth2025 Geopolitical Influence & Verified Technical Trade Signals - mfd.ru
Why Elicio Therapeutics Inc. stock is favored by top institutionsWeekly Gains Summary & Weekly Stock Performance Updates - mfd.ru
Trading Systems Reacting to (ELTX) Volatility - Stock Traders Daily
Elicio Therapeutics reports inducement grants - TipRanks
Elicio Therapeutics Reports Inducement Grants - The Manila Times
New Elicio hire gets 30,300 options vesting over 4 years - Stock Titan
What are the future prospects of Elicio Therapeutics Inc.Stop Loss & AI Optimized Trading Strategy Guides - mfd.ru
Is Elicio Therapeutics (NASDAQ:ELTX) Using Debt In A Risky Way? - simplywall.st
How Elicio Therapeutics Inc. (ELTX) Affects Rotational Strategy Timing - Stock Traders Daily
Aug Setups: Does Elicio Therapeutics Inc offer margin of safetyNew Guidance & Smart Investment Allocation Tips - baoquankhu1.vn
(ELTX) and the Role of Price-Sensitive Allocations - Stock Traders Daily
While insiders own 33% of Elicio Therapeutics, Inc. (NASDAQ:ELTX), individual investors are its largest shareholders with 55% ownership - Yahoo Finance
Loss Report: Is SandRidge Energy Inc a stock for growth or value investorsJuly 2025 Trade Ideas & Safe Swing Trade Setups - baoquankhu1.vn
Retail Trends: Does Elicio Therapeutics Inc offer margin of safetyWall Street Watch & Technical Buy Zone Confirmation - baoquankhu1.vn
Why Elicio Therapeutics Inc. stock is seen as undervaluedEarnings Overview Summary & Risk Controlled Swing Alerts - bollywoodhelpline.com
Responsive Playbooks and the ELTX Inflection - Stock Traders Daily
Aug Volume: Will Elicio Therapeutics Inc benefit from AI trendsJuly 2025 Macro Moves & Weekly Setup with High ROI Potential - baoquankhu1.vn
Profit Review: What are the future prospects of Elicio Therapeutics Inc2025 Key Highlights & Fast Entry High Yield Tips - baoquankhu1.vn
Biotech Elicio offers 22,400 stock options to attract new hires - Stock Titan
Analysts Are Bullish on Top Healthcare Stocks: Ascendis Pharma (ASND), Elicio Therapeutics (ELTX) - The Globe and Mail
Elicio Therapeutics (ELTX) Upgraded to Buy: Here's Why - Eastern Progress
Is Quest Diagnostics (DGX) Stock Outpacing Its Medical Peers This Year? - Eastern Progress
Why Elicio Therapeutics Inc. stock could benefit from AI revolutionJuly 2025 Catalysts & Safe Entry Trade Signal Reports - Улправда
Why CBLL stock attracts strong analyst attention - Улправда
How rising interest rates impact Elicio Therapeutics Inc. stock2025 Technical Overview & Reliable Volume Spike Trade Alerts - ulpravda.ru
KRAS Inhibitors Market Dynamics Indicate Upward Trajectory Through 2034, Reports DelveInsight | Pfizer, Roche, Chugai, Genentech, Revolution Medicines, Eli Lilly, Merck, Taiho, Astex Pharma, Elicio - Barchart.com
How Elicio Therapeutics Inc. stock reacts to Fed rate cutsREITs Market Trends & Free High Margin Investment Plays - Улправда
Understanding the Setup: (ELTX) and Scalable Risk - Stock Traders Daily
Elicio Therapeutics Inc Azioni (ELTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):